218 related articles for article (PubMed ID: 22743138)
1. Best practices for companion diagnostic and therapeutic development: translating between the stakeholders.
Love D; Stratton E; Stocum M
N Biotechnol; 2012 Sep; 29(6):689-94. PubMed ID: 22743138
[TBL] [Abstract][Full Text] [Related]
2. Do companion diagnostics make economic sense for drug developers?
Agarwal A
N Biotechnol; 2012 Sep; 29(6):695-708. PubMed ID: 22575210
[TBL] [Abstract][Full Text] [Related]
3. US FDA perspective on challenges in co-developing in vitro companion diagnostics and targeted cancer therapeutics.
Philip R; Carrington L; Chan M
Bioanalysis; 2011 Feb; 3(4):383-9. PubMed ID: 21338257
[TBL] [Abstract][Full Text] [Related]
4. The biomarker is not the end.
Nohaile M
Drug Discov Today; 2011 Oct; 16(19-20):878-83. PubMed ID: 21888986
[TBL] [Abstract][Full Text] [Related]
5. Predictive markers in early research and companion diagnostic developments in oncology.
Pickl M; Ruge E; Venturi M
N Biotechnol; 2012 Sep; 29(6):651-5. PubMed ID: 22484859
[TBL] [Abstract][Full Text] [Related]
6. Companion diagnostics: a regulatory perspective from the last 5 years of molecular companion diagnostic approvals.
Roscoe DM; Hu YF; Philip R
Expert Rev Mol Diagn; 2015; 15(7):869-80. PubMed ID: 26109316
[TBL] [Abstract][Full Text] [Related]
7. Perspective for the development of companion diagnostics and regulatory landscape to encourage personalized medicine in Japan.
Tazawa Y
Breast Cancer; 2016 Jan; 23(1):19-23. PubMed ID: 25605056
[TBL] [Abstract][Full Text] [Related]
8. [Diagnostic kits in parasitology: which controls?].
Rossi P
Parassitologia; 2004 Jun; 46(1-2):145-9. PubMed ID: 15305705
[TBL] [Abstract][Full Text] [Related]
9. Molecular tools for companion diagnostics.
Zieba A; Grannas K; Söderberg O; Gullberg M; Nilsson M; Landegren U
N Biotechnol; 2012 Sep; 29(6):634-40. PubMed ID: 22634023
[TBL] [Abstract][Full Text] [Related]
10. Evaluating the value of genomic diagnostics: implications for clinical practice and public policy.
Issa AM
Adv Health Econ Health Serv Res; 2008; 19():191-206. PubMed ID: 19548519
[TBL] [Abstract][Full Text] [Related]
11. Some imminent but overlooked preanalytical and analytical challenges currently facing biomarkers and companion diagnostics.
Halim AB
Ann N Y Acad Sci; 2015 Jun; 1346(1):63-70. PubMed ID: 25758153
[TBL] [Abstract][Full Text] [Related]
12. Personalized medicine: elusive dream or imminent reality?
Lesko LJ
Clin Pharmacol Ther; 2007 Jun; 81(6):807-16. PubMed ID: 17505496
[TBL] [Abstract][Full Text] [Related]
13. Precision medicine: what's all the fuss about?
Barker R
Scand J Clin Lab Invest Suppl; 2016; 245():S2-5. PubMed ID: 27542001
[TBL] [Abstract][Full Text] [Related]
14. Translational research: precision medicine, personalized medicine, targeted therapies: marketing or science?
Marquet P; Longeray PH; Barlesi F; ; Ameye V; Augé P; Cazeneuve B; Chatelut E; Diaz I; Diviné M; Froguel P; Goni S; Gueyffier F; Hoog-Labouret N; Mourah S; Morin-Surroca M; Perche O; Perin-Dureau F; Pigeon M; Tisseau A; Verstuyft C
Therapie; 2015; 70(1):1-19. PubMed ID: 25679189
[TBL] [Abstract][Full Text] [Related]
15. Point-of-care diagnostics: will the hurdles be overcome this time?
Huckle D
Expert Rev Med Devices; 2006 Jul; 3(4):421-6. PubMed ID: 16866639
[TBL] [Abstract][Full Text] [Related]
16. New ways of insulin delivery.
Heinemann L
Int J Clin Pract Suppl; 2011 Feb; (170):31-46. PubMed ID: 21323811
[TBL] [Abstract][Full Text] [Related]
17. The clinical benefits, ethics, and economics of stratified medicine and companion diagnostics.
Trusheim MR; Berndt ER
Drug Discov Today; 2015 Dec; 20(12):1439-50. PubMed ID: 26542060
[TBL] [Abstract][Full Text] [Related]
18. [Biomarkers: "Found in translation"].
Lockhart BP; Walther B
Med Sci (Paris); 2009 Apr; 25(4):423-30. PubMed ID: 19409197
[TBL] [Abstract][Full Text] [Related]
19. Drug-diagnostic co-development: challenges and issues.
Shimazawa R; Ikeda M
Expert Rev Mol Diagn; 2016; 16(2):187-204. PubMed ID: 26651878
[TBL] [Abstract][Full Text] [Related]
20. [International comparison and regulatory issues of the molecular targeted therapy development].
Iwasaku M; Kawakami K
Nihon Rinsho; 2015 Aug; 73(8):1403-8. PubMed ID: 26281697
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
